Clinical Trials Browser

Nasopharyngeal Carcinoma

Advanced Refractory Solid Tumors

Colorectal Neoplasms

Advanced Renal Cell Carcinoma (aRCC)

Osteosarcoma

Gastrointestinal Stromal Tumors

Cholangiocarcinoma

Biliary Tract Neoplasms

Stomach Neoplasms

Colonic Neoplasms

Gastrointestinal Neoplasms

Pancreatic Neoplasms

Neoplasm Metastasis

Colorectal Neoplasms

Carcinoma, Ovarian Epithelial

Rectal Neoplasms

Lung Neoplasms

Uterine Cervical Neoplasms

Rectal Neoplasms

Uterine Cervical Neoplasms

Locally Advanced Rectal Carcinoma

Esophageal Squamous Cell Carcinoma

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Ovarian Epithelial

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung

Meningeal Carcinomatosis

Carcinoma, Non-Small-Cell Lung

Advanced Pancreatic Cancer

Squamous Non-small Cell Lung Cancer

Neoplasms, Multiple Primary

HER2-positive Breast Cancer

Clinical Trials

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors

CEIL

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients

A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

SPRING

Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer

Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.

A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer

TRACE-LE

Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer

Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2

A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer

Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer

A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLC

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

CPOG035-01

KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer